ubmslateRN-logo-ubm

RN Mobile Menu

Topics:

Rheumatology Network

Biologic Therapy Not a Factor in Melanoma Risk

Rheumatoid arthritis patients are inherently at higher risk of melanoma, but a new study shows that biologics do not increase that risk.  (©Charnsitr/Shutterstock.com)

 

Recent Content

©PuwadolJaturawutthichai/Shutterstock.com

Treg cells are more prevalent in patients with juvenile idiopathic arthritis and active inflammation, as compared to patients in remission.

©Custommedia/Shutterstock.com

Researchers say it's not necessary to take high body mass index into account in axial spondyloarthritis.

(©Burlingham/Shutterstock.com)

"Avoid long-acting opioids whenever possible," says a physician who linked a higher risk of mortality to long-acting opioids used for chronic pain.

(©Charnsitr/Shutterstock.com)

Rheumatoid arthritis patients are inherently at higher risk of melanoma, but a new study shows that biologics do not increase that risk.

Physicians should understand the key features of MACRA and changes that lie ahead, say Duke University healthcare policy experts writing in JAMA.

©Lightspring/Shuttersstock.com

Polymyalgia rheumatica and giant cell arteritis frequently occur together. And, while both share elevated inflammatory markers, their diagnosis and treatment differ, researchers write in JAMA.

©SebastianKaulitzki/Shutterstock.com

EULAR 2016: Cardiovascular disease risk in rheumatoid arthritis is quite different from risk factors in the general population. Risk calculators should be different too, experts say.

By clicking Accept, you agree to become a member of the UBM Medica Community.